Summary

at San Diego, California and other locations
study started
estimated completion

Description

Summary

The primary objective of this study is to evaluate the rate of stroke and/or death in patients treated with the Wingspan Stent System, according to the Indications for Use, within 72 hours post procedure.

Official Title

WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study

Details

This research study is a Food and Drug Administration (FDA) mandated post market surveillance study of the Wingspan® Stent System, also known as the WEAVE™ Trial. The purpose of this trial is to fulfill a FDA requirement to evaluate the rate of stroke and/or death within 72 hours of the procedure, in patients who have a Wingspan Stent implanted in accordance with the Indications for Use.

Keywords

Intracranial AtherosclerosisWingspan Stent SystemWingspan StentIntracranial StentIschemic StrokeIntracranial Atherosclerotic DiseaseIntracranial StenosisAtherosclerosisIntracranial Arteriosclerosis

Eligibility

All patients for whom treatment with the Wingspan Stent System is considered.

Locations

  • UCSD Medical Center
    San DiegoCalifornia92103United States
  • Southern California Permanente Medical Group
    Los AngelesCalifornia90027United States
  • Cedars-Sinai Medical Center
    Los AngelesCalifornia90048United States

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Stryker Neurovascular
ID
NCT02034058
Study Type
Interventional
Last Updated